Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2005-08-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75016), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE DE PASSY : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE DE PASSY is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75016),
this company of category PME
shows in 2023 a net income positive of 150 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE DE PASSY (SIREN 483709275)
Indicator
2023
2016
2015
Revenue
N/C
N/C
N/C
Net income
149 873 €
171 372 €
129 050 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE CENTRALE DE PASSY generates positive net income of 150 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 129 k€ -> 150 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
149 873 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 74%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
74.347%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.162%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE DE PASSY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2023
Debt ratio
103.305
82.151
74.347
Financial autonomy
43.459
47.567
50.162
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
74.352023
2015
2016
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+16 pts over 3 years
In 2023, the debt ratio of PHARMACIE CENTRALE DE PASSY (74.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.16%2023
2015
2016
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good-24 pts over 3 years
In 2023, the financial autonomy of PHARMACIE CENTRALE DE PASSY (50.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 240.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
240.643
Liquidity indicators evolution PHARMACIE CENTRALE DE PASSY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2023
Liquidity ratio
139.904
160.615
240.643
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
240.642023
2015
2016
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good+18 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE CENTRALE DE PASSY (240.64) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE CENTRALE DE PASSY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE CENTRALE DE PASSY is estimated at
1 768 422 €
(range 1 075 462€ - 2 486 005€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1075k€1768k€2486k€
1 768 422 €Range: 1 075 462€ - 2 486 005€
NAF 5 année 2023
Valuation method used
Net Income Multiple
149 873 €
×
11.8x
=1 768 423 €
Range: 1 075 463€ - 2 486 006€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE DE PASSY with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE DE PASSY
What is the revenue of PHARMACIE CENTRALE DE PASSY ?
The revenue of PHARMACIE CENTRALE DE PASSY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE DE PASSY profitable?
Yes, PHARMACIE CENTRALE DE PASSY generated a net profit of 150 k€ in 2023.
Where is the headquarters of PHARMACIE CENTRALE DE PASSY ?
The headquarters of PHARMACIE CENTRALE DE PASSY is located in PARIS (75016), in the department Paris.
Where to find the tax return of PHARMACIE CENTRALE DE PASSY ?
The tax return of PHARMACIE CENTRALE DE PASSY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE DE PASSY operate?
PHARMACIE CENTRALE DE PASSY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart